Dr. Melnyk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1100 N 19th St
Suite 1a
Abilene, TX 79601Phone+1 325-672-4368Fax+1 325-672-3108
Education & Training
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1993 - 1996
University of AlbertaClass of 1988
Certifications & Licensure
TX State Medical License 1995 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Super Doctor SuperDoctors.com
Clinical Trials
- Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2012 Apr 01
- A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen Start of enrollment: 2014 Apr 09
Publications & Presentations
PubMed
- 67 citationsGemcitabine, Cisplatin, and sunitinib for metastatic urothelial carcinoma and as preoperative therapy for muscle-invasive bladder cancer.Matthew D. Galsky, Noah M. Hahn, Thomas Powles, Beth A. Hellerstedt, Seth P. Lerner
Clinical Genitourinary Cancer. 2013-06-01 - 22 citationsPhase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA-Mutant Cancers.Komal Jhaveri, Matthew T. Chang, Dejan Juric, Cristina Saura, Valentina Gambardella
Clinical Cancer Research. 2021-01-15 - 11 citationsEvaluation of Miracle Mouthwash plus Hydrocortisone Versus Prednisolone Mouth Rinses as Prophylaxis for Everolimus‐Associated Stomatitis: A Randomized Phase II StudyVicky E. Jones, Kristi McIntyre, Devchand Paul, Sharon Wilks, Sharon M. Ondreyco
The Oncologist. 2019-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
